Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806

    NEXT STORY
    Translate Bio to Participate in Upcoming Investor Conferences
    PREV STORY
    XORTX Shares Findings of New Diabetes Study Supporting Uric Acid as an Independent Risk Factor
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers

    author_avatar
    NASDAQ Market News

    Hemispherx Biopharma Names Ellen Lintal as New Chief Accounting Officer

    author_avatar
    NASDAQ Market News

    ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference

    BOSTON, Dec. 21, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), today announced ...

    author_avatar
    NASDAQ Market News